Newsmeme!
Discover News you didn't know existed
Dec. 5 (Bloomberg) -- Chugai Pharmaceutical Co. fell the most in five weeks in Tokyo trading after U.S. regulators delayed their decision for a second time on whether to approve the company's rheumatoid arthritis drug Actemra.
No tags found at this time. Be the first to tag this news item, learn more.
Chugai Pharma Falls After FDA Seeks Data on Actemra (Update3) - Bloomberg
Dec. 5 (Bloomberg) -- Chugai Pharmaceutical Co. fell the most in five weeks in Tokyo trading after U.S. regulators delayed their decision for a second time on whether to approve the company's rheumatoid arthritis drug Actemra. Chugai Pharma sank 133 ...
Chugai Pharma Falls After FDA Seeks Data on Actemra (Update3) - Bloomberg
Dec. 5 (Bloomberg) -- Chugai Pharmaceutical Co. fell the most in five weeks in Tokyo trading after U.S. regulators delayed their decision for a second time on whether to approve the company's rheumatoid arthritis drug Actemra. Chugai Pharma sank 133 ...
None found at this time.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |